As of 2025-04-21, the Relative Valuation of CureVac NV (CVAC) is 12.21 USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.12 USD, the upside of CureVac NV based on Relative Valuation is 291.4%.
The range of the Relative Valuation is 9.72 - 14.90 USD.
| Range | Selected | |
| Trailing P/E multiples | 11.8x - 15.3x | 13.6x |
| Forward P/E multiples | 11.2x - 14.3x | 12.8x |
| Fair Price | 9.72 - 14.90 | 12.21 |
| Upside | 211.5% - 377.5% | 291.4% |
| Date | P/E |
| 2025-04-17 | 3.80 |
| 2025-04-16 | 3.90 |
| 2025-04-15 | 3.94 |
| 2025-04-14 | 3.98 |
| 2025-04-11 | 3.89 |
| 2025-04-10 | 3.48 |
| 2025-04-09 | 3.63 |
| 2025-04-08 | 3.31 |
| 2025-04-07 | 3.23 |
| 2025-04-04 | 3.16 |
| 2025-04-03 | 3.46 |
| 2025-04-02 | 3.48 |
| 2025-04-01 | 3.31 |
| 2025-03-31 | 3.37 |
| 2025-03-28 | 3.63 |
| 2025-03-27 | 3.41 |
| 2025-03-26 | 3.47 |
| 2025-03-25 | 3.55 |
| 2025-03-24 | 3.66 |
| 2025-03-21 | 3.52 |
| 2025-03-20 | 3.62 |
| 2025-03-19 | 3.70 |
| 2025-03-18 | 3.68 |
| 2025-03-17 | 3.74 |
| 2025-03-14 | 3.67 |
| 2025-03-13 | 3.69 |
| 2025-03-12 | 3.86 |
| 2025-03-11 | 3.85 |
| 2025-03-10 | 3.56 |
| 2025-03-07 | 3.70 |
| 2025-03-06 | 3.90 |
| 2025-03-05 | 3.85 |
| 2025-03-04 | 3.66 |
| 2025-03-03 | 3.75 |
| 2025-02-28 | 3.78 |
| 2025-02-27 | 3.73 |
| 2025-02-26 | 3.90 |
| 2025-02-25 | 3.86 |
| 2025-02-24 | 3.98 |
| 2025-02-21 | 4.02 |
| 2025-02-20 | 4.00 |
| 2025-02-19 | 4.01 |
| 2025-02-18 | 4.29 |
| 2025-02-14 | 4.45 |
| 2025-02-13 | 4.45 |
| 2025-02-12 | 4.47 |
| 2025-02-11 | 4.31 |
| 2025-02-10 | 4.52 |
| 2025-02-07 | 4.36 |
| 2025-02-06 | 4.54 |